Cognition/Performance/Mood

Dynamine

Stimulant alkaloid from kucha tea marketed for acute energy and focus, with preliminary human evidence and unknown long-term safety profile.

Dynamine

Dynamine

40
score
C
evidence
Caution
risk

Proven Benefits

01May increase subjective energy
02May improve cognitive performance
03May enhance mood

Chemical Forms

Recommended
  • Dynamine (methylliberine)
Avoid
  • Unstandardized kucha tea extracts (unknown alkaloid content)
Expert Note

Dynamine is a standardized preparation of methylliberine, ensuring consistent dosing. Non-standardized herbal sources like raw kucha tea vary widely in alkaloid content and may deliver unpredictable amounts of caffeine and other xanthines.

Protocol

Amount
100-200 mg
Frequency
Once daily, or only as needed
When
Morning or early afternoon; avoid within 8 hours of bedtime due to stimulant effects.

Condition-Based Dosing

First-time or stimulant-sensitive users
50 mg to assess tolerance before increasing
Experienced caffeine users seeking acute focus
100-200 mg, taken as needed

Safety & Limits

Upper Safe Limit
300 mg/day (highest dose studied in short-term human trials)
Cycling
4 weeks on, 1-2 weeks off; or use only on demanding days rather than daily.

Contraindications

Pregnancy or breastfeeding — stimulant safety not established
Cardiovascular disease or arrhythmias — may increase heart rate and blood pressure
Anxiety disorders or panic disorder — may worsen symptoms
Bipolar disorder or mania — stimulants may trigger mood episodes
Hypertension — uncontrolled blood pressure may be aggravated
Concurrent use of prescription stimulants (e.g., amphetamines, methylphenidate) — additive effects and cardiovascular risk

Synergies

Caffeine appears to complement methylliberine's adenosine blockade, with some studies using the combination.

L-theanine can smooth the stimulant edge and reduce jitteriness.

Avoid Combining With

  • Other stimulants (additive cardiovascular load — monitor total daily stimulant intake)
  • Alcohol (may mask intoxication and increase risky behavior)
  • Late-day dosing (disrupts sleep architecture)
Updated Invalid Date